Сердце спортсмена. Актуальные проблемы спортивной кардиологии - Елена Анатольевна Гаврилова
Шрифт:
Интервал:
Закладка:
44. Kass, L. Effect of magnesium supplementation on blood pressure: a meta-analysis / L. Kass, J. Weekes, L. Carpenter // Eur J Clin Nutr. – 2012. – V. 66. – № 4. – P. 411–8.
45. Kearney, P. M. Global burden of hypertension: analysis of worldwide data / P. M. Kearney, M. Whelton, K. Reynolds et al. // Lancet. – 2005. – V. 365. – P. 217–223.
46. Kim, C. H. Exercise-induced hypertension is associated with angiotensin II activity and total nitric oxide / C. H. Kim, Y. Park, M. Y. Chun, Y. J. Kim // Medicine. – 2020. – V. 99. – № 27. – P. e20943.
47. Kim, Y. J. Excessive exercise habits in marathoners as novel indicators of masked hypertension / Y. J. Kim, Y. Park, D. H. Kang, C. H. Kim // Biomed Res Int. – 2017:134-2842.
48. Kojda, G. Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? / G. Kojda, R. Hambrecht // Cardiovasc Res. – 2005. – № 67. – P. 187–197.
49. Kouidi, E. White coat hypertension detected during screening of male adolescent athletes. //Am J Hypertens. – 1999. – № 12. – Р.: 223-6.
50. Leischik, R. Exercise-induced arterial hypertension – an independent factor for hypertrophy and a ticking clock for cardiac fatigue or atrial fibrillation in athletes? / R. Leischik, N. Spelsberg, H. Niggemann, B. Dworrak, K. Tiroch // Research. – 2014. – 12:3:105.
51. Li, Y. X. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials / Li Y. X. Zhang, L. C. Del Gobbo, A. Rosanoff et al. // Hypertension. – 2016. – V. 68. – № 2. – P. 324–33.
52. Ljungqvist A. The International Olympic Committee (IOC) consensus statement on periodic health evaluation of elite athletes / A. Ljungqvist, P. J. Jenoure, L. Engebretsen et al. // Clin J Sport Med. – 2009. – № 19. – P. 347–65.
53. Lovic, D. Left ventricular hypertrophy in athletes and hypertensive patients / D. Lovic, P. Narayan, A. Pittaras et al. // Clin Hypertens (Greenwich). – 2017. – V. 4. – № 19. – P. 41.
54. Mitchell, J. H. Task Force 8: Classification of Sports / J. H. Mitchell, W. Haskell, P. Snell, S. P. Van Camp // J Am Coll Cardiol. – 2005. – V. 45. – № 8. – P. 1364–1367.
55. Mohammed, L. M. Exercise-Induced Hypertension in Healthy Individuals and Athletes: Is it an Alarming Sign? / L. M. Mohammed, M. Dhavale, M. K. Abdelaal et al. // Cureus. – 2020. – № 12. – Р. 12.
56. Neil, A. Effects of isometric resistance training on resting blood pressure: individual participant data meta-analysis / Neil A. Smart, D. Way, D. Carlson et al. // J Hypertens. – 2019. – V. 10. – № 37. – P. 1927–1938.
57. Niebauer, J. Recommendations for participation in competitive sports of athletes with arterial hypertension: a position statement from the sports cardiology section of the European Association of Preventive Cardiology (EAPC) / J. Niebauer, M. Börjesson, F. Carre et al. // Eur Heart J. – 2018. – V. 39. – № 40. – P. 3664–3671.
58. Olesçuck, I. F. Melatonin and brown adipose tissue: novel insights to a complex interplay / I. F. Olesçuck, L. S. Camargo, PV. V. Carvalho, CA. P. Souza, C. C. Gallo, F. G. do Amaral // Melatonin Research. – 2019. – V. 2. – № 4. – P. 25–41.
59. Pandi-Perumal, S. R. Melatonin and human cardiovascular disease / Pandi-Perumal S. R., BaHammam A. S., Ojike N. I. et al. // J Cardiovasc Pharmacol Ther. – 2017. – V. 22. – № 2. – Р. 122–32.
60. Pelliccia, A. The ESC Textbook of Sports Cardiology / A. Pelliccia, H. Heidbuchel, D. Corrado et al. // Oxford University Press. – 2019. – 478 p.
61. Pelliccia A, 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. / A. Pelliccia, S. Sharma, Gati S. et al. / Eur Heart J. – 2021. PMID: 32860412.
62. Pescatello, B. A. Exercise and hypertension. Medicine amp;science in sports amp;exercise / L. M. Pescatello, B. A. Franclin, R. Fagard et al. // J. Amer. Coll. Sports Med. – 2004. – V. 36. – № 3. – P. 533–553.
63. Rahbarghazi, A. Role of melatonin in the angiogenesis potential; highlights on the cardiovascular disease / A. Rahbarghazi, M. Siahkouhian, R. Rahbarghazi et al. // J Inflamm (Lond). – 2021. – V. 18. – № 1. – P. 4.
64. Rasmussen, J. J., Schou, M., Madsen, P. L., et al. Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma? // J. J. Rasmussen, M. Schou, P. L. Madsen et al. // J Hypertens. – 2018. – V. 36. – Р.: 277-85.
65. Schleich, K. T. Hypertension in Athletes and Active Populations / K. T. Schleich, M. K. Smoot, M. E. Ernst // Curr Hypertens Rep. – 2016. – V. 18. – № 11. – P. 77.
66. Schultz, M. G. Exercise-induced hypertension, cardiovascular events, and mortality in patients undergoing exercise stress testing: a systematic review and meta-analysis / M. G. Schultz, P. Otahal, V. J. Cleland et al. // Am J Hypertens. – 2013. – № 26. – P. 357–366.
67. Shimizu, I. Physiological and pathological cardiac hypertrophy / I. Shimizu, T. Minamino / J Mol Cell Cardiol. – 2016. – № 97. – P. 245–62.
68. Sorof, J. M. Carotid arteryintimalmedial thickness and left ventricular hypertrophy in children with elevated blood pressure / J. M. Sorof, A. V. Alexandrov, G. Cardwell, R. J. Portman // Pediatrics. – 2003. – V. 111. – P. 61.
69. Tahir, E. Acute impact of an endurance race on cardiac function and biomarkers of myocardial injury in triathletes with and without myocardial fibrosis / E. Tahir, B. Scherz, J. Starekova et al. // Eur J Prev Cardiol. – 2020. – № 27. – P. 94–104.
70. Unger, T. International Society of Hypertension global hypertension practice guidelines / T. Unger, С. Borghi, F. Charchar et al. // Journal of Hypertension. – 2020. – V. 38. – № 6. – P. 982–1004.
71. Wang, P. Keeping pace with ACE: Are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents?// P. Wang, M. N. Fedoruk, J., L. Rupert // Sport Med. – 2008. – № 38. – Р. 1065–79.
72. Weiner, R.
